Researchers have succeeded in growing large numbers of stem cells from adult human hearts into new heart muscle cells. – Dutch researchers at University Medical Center Utrecht and the Hubrecht Institute have succeeded in growing large numbers of stem cells from adult human hearts into new heart muscle cells. A breakthrough in stem cell research.
Special issue of JACC features intriguing link between statins and Atrial Fibrillation (AF) prevention, tools to ensure the highest-quality AF care, and more. – When we’re young, a racing heart often means love is in the air. If you’re a “baby boomer,” it might mean you’ve just joined the 2.2 million Americans who have atrial fibrillation (AF), an irregularity in the heart’s rhythm that grows more common as we age and markedly increases the risk for stroke.
There has been much concern about the possibility of increased risk for heart attack and stroke in users of NSAID drugs, particularly COX-2 selective NSAIDs such as celecoxib. – COX-2 inhibitors like Celecoxib have come under scrutiny lately due to adverse cardiovascular side-effects stemming from COX-2 reduction. In both fruit fly and rat models, researchers reveal another adverse effect of Celecoxib; this drug can induce arrhythmia. More interestingly, this effect is independent of the COX-2 enzyme.
Researchers implant embryonic cells into damaged hearts and prevent life-threatening heart arrhythmias.
– When researchers at Cornell, the University of Bonn and the University of Pittsburgh transplanted living embryonic heart cells into cardiac tissue of mice that had suffered heart attacks, the mice became resistant to cardiac arrhythmias, thereby avoiding one of the most dangerous and fatal consequences of heart attacks.
